Support NET Research
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading funder of neuroendocrine tumor (NET) research, having funded more than $36 million in research projects aimed at advancing improved treatments for neuroendocrine tumors. NETRF funds are solely provided by private donations from around the globe. There are many ways to support neuroendocrine tumor (NET) research, such a making a gift, volunteering, or hosting a fundraising event. We hope that the information you find on this page is helpful and will entice you to take the next step in getting involved with NETRF.
Your gift will fund world-class research, empower and educate NET survivors and families and bolster the field of NET research. Learn more about the impact of your gift .
The latest in NET News
Cabozantinib Evokes Response in Some Clinical Trial Participants with Metastatic Pheo/Para
The results of a phase 2 clinical trial, the Natalie Trial, suggest that the drug
Lutathera® Approved by FDA as First Medication for Pediatric Patients with Certain NETs
The U.S. Food and Drug Administration approved Lutathera® as the first therapy specifically for patients
Carrie Camino Joins NETRF’s Board of Directors
Carrie Camino joined the NETRF Board of Directors in April of 2024. Carrie is a